Courses of chest x-ray findings of sarcoidosis generally reveal modifications through corticosteroid treatment.
This report is about a study conducted on various courses of chest x-ray findings obtained from 57 patients with sarcoidosis who were observed for more than 12 months and underwent treatment by administration of corticosteroid. The results of the study and conclusions obtained are as follows.
1. All chest x-ray courses were classified into 5 types; recurrent type (47%), disappearing type (33%), improving type (16%), stationary type (4%) and progressive type (0%). It was noted that the patients included in the recurrent type were about one half of the total.
2. Sixty-seven percent of the patients in the recurrent type suffered relapses more than 3 times, most of them being observed for over 5 years.
3. Of all the patients who had only BHL (bilateral hilar lymphadenopathy) in chest roentgenograms at the beginning of observation, 45% of them developed other abnormalities in the lung field later. This fact shows that even patients who have only BHL should be kept under careful observation over a long time.
4. Chest roentgenograms showed that patients showing no characteristic BHL and showing lung field abnormalities at least once during the x-ray course were about 1/3 (28%) of the total, indicating a need for caution. The number of patients whose chest x-ray findings showed only lung field abnormalities all through the observed course of the disease was only 2 (4% of all patients). In such patients it is important to make a survey of the past x-ray findings to discover BHL.
5. Chest roentgenograms showed that recurrence took place in 74% of the patients who had had lung lesions of sarcoidosis and in 59% of the patients who had had only BHL. However, there was no significant difference in incidence.
6. Corticosteroid was administered to 65% of all the patients. This drug was considered to be effective.
7. Recurrence of sarcoidosis occured in 58% of patients given corticosteroid and 40% of the patients not given it, but the ratio of recurrence did not revealed a significant difference.
8. Tapering dosages of corticosteroid reduced to a dosage equivalent to 1mg of less than 1mg equivalent of betamethazone per day induced relapses in the patients of the recurrent type and moreover 78% of them showed the relapses within 4 months after the start of the administration of the tapering dosage 1mg per day. Consequently, it is desired to taper the dosage of corticosteroid gradually from 1mg per day to 0.75mg, 0.5mg and 0.25mg, respectively, each dosage being administered for 3 to 4 months after the reduction of the dosage.
抄録全体を表示